The clinical classification of malignant tumours: the TNM system.
作者信息
Sellers A H
出版信息
Can Med Assoc J. 1971 Oct 23;105(8):836 passim.
Abstract
摘要
相似文献
1
The clinical classification of malignant tumours: the TNM system.恶性肿瘤的临床分类：TNM 系统。
Can Med Assoc J. 1971 Oct 23;105(8):836 passim.
2
[TNM-classification of malignant tumors. General rules].[恶性肿瘤的TNM分类。一般规则]
Arch Geschwulstforsch. 1971;37(3):266-84.
3
[The TNM system of clinical classification of malignant neoplasms].[恶性肿瘤的TNM临床分类系统]
SSO Schweiz Monatsschr Zahnheilkd. 1975 Jan;85(1):75-9.
4
[Proposal of the Heildelberg clinic for the classification of malignant tumors in the ENT region according to the TNM system].[海德堡诊所关于根据TNM系统对耳鼻喉区域恶性肿瘤进行分类的提议]
Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1967;188(2):398-403.
5
[Proceedings: TNM classification in controlled clinical trials (author's transl)].
Langenbecks Arch Chir. 1973;334:237-44.
6
Head and neck cancer. Oral cavity: primary lesion.
JAMA. 1971 Feb 8;215(6):953-4.
7
[Proceedings: TNM findings and surgical treatment (author's transl)].
Langenbecks Arch Chir. 1973;334:231-6.
8
[Proceedings: TNM system and surgery (author's transl)].[会议论文集：TNM 系统与外科手术（作者译）]
Langenbecks Arch Chir. 1973;334:225-30. doi: 10.1007/BF01286563.
9
[Classification of TNM of the International Union for Cancer Prevention].[国际癌症预防联盟TNM分类法]
Acta Oncol (Madr). 1970 Jan-Jun;9(1):56-84.
10
[Committee of TNM classification of the UICC].[国际抗癌联盟TNM分类委员会]
Acta Oncol (Madr). 1968 Jul-Dec;7(2):254-64.
引用本文的文献
1
Heart failure 'the cancer of the heart': the prognostic role of the HLM score.心力衰竭是“心脏的癌症”：HLM 评分的预后作用。
ESC Heart Fail. 2024 Feb;11(1):390-399. doi: 10.1002/ehf2.14594. Epub 2023 Nov 27.
2
Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification.子宫内膜异位症的分类、分期及报告系统：迈向被普遍接受的子宫内膜异位症分类之路的综述
Hum Reprod Open. 2021 Oct 22;2021(4):hoab025. doi: 10.1093/hropen/hoab025. eCollection 2021.
3
Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification.子宫内膜异位症的分类、分期及报告系统：通向普遍接受的子宫内膜异位症分类之路的综述
Facts Views Vis Obgyn. 2021 Dec;13(4):305-330. doi: 10.52054/FVVO.13.3.025.
4
Exploring the Potential Different Outcomes Associated With the Different Phenotypes Under the Shared Pathologic T3N0 Designation.探索在共同的病理T3N0命名下，不同表型所关联的潜在不同结果。
JTO Clin Res Rep. 2021 May 18;2(6):100186. doi: 10.1016/j.jtocrr.2021.100186. eCollection 2021 Jun.
5
Hsa_circ_0076305 induces migration-proliferation dichotomy in gastric cancer.人源环状RNA hsa_circ_0076305在胃癌中诱导迁移-增殖二分法。
Oncol Lett. 2021 Mar;21(3):220. doi: 10.3892/ol.2021.12481. Epub 2021 Jan 21.
6
PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.PRMT6 在肺腺癌中通过调节 p18 发挥致癌作用。
Mol Med Rep. 2020 Oct;22(4):3161-3172. doi: 10.3892/mmr.2020.11402. Epub 2020 Aug 3.
7
A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed.癌症可治愈性综述：需要为新型治疗选择付出更多努力。
Cancers (Basel). 2019 Nov 13;11(11):1782. doi: 10.3390/cancers11111782.
8
Real-time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study.实时离体人淋巴结中受癌症侵犯的灌流研究（REPLICANT）：一项可行性研究。
J Pathol. 2020 Mar;250(3):262-274. doi: 10.1002/path.5367. Epub 2019 Dec 22.
9
Additional malignancies in patients with gastrointestinal stromal tumors (GIST): incidence, pathology and prognosis according to a time of occurrence-based classification.胃肠道间质瘤（GIST）患者的其他恶性肿瘤：基于发病时间的分类方法的发生率、病理学和预后。
Clin Transl Oncol. 2019 May;21(5):646-655. doi: 10.1007/s12094-018-1966-5. Epub 2018 Oct 27.
10
Accuracy of cause of death data routinely recorded in a population-based cancer registry: impact on cause-specific survival and validation using the Geneva Cancer Registry.基于人群的癌症登记处常规记录的死亡原因数据的准确性：对特定病因生存率的影响以及使用日内瓦癌症登记处进行的验证
BMC Cancer. 2013 Dec 27;13:609. doi: 10.1186/1471-2407-13-609.
本文引用的文献
1
Carcinoma of the Breast. II-Criteria of Operability.乳腺癌。II - 可手术性标准
Ann Surg. 1943 Dec;118(6):1032-51. doi: 10.1097/00000658-194312000-00010.
2
An evaluation of the proposed international clinical staging system for cancer of the breast.对拟议的乳腺癌国际临床分期系统的评估。
J Natl Cancer Inst. 1960 Jul;25:13-24.
3
Clinical staging system for cancer and end results reporting.癌症临床分期系统与终末结果报告
CA Cancer J Clin. 1961 Mar-Apr;11:42-7. doi: 10.3322/canjclin.11.2.42.
4
A clinical trial of TNM staging of breast cancer. Ontario, 1960-1962.乳腺癌TNM分期的一项临床试验。安大略省，1960年至1962年。
Int J Cancer. 1966 Sep 15;1(5):515-24. doi: 10.1002/ijc.2910010511.
5
Comparison of the international and American systems for the staging of breast cancer.国际与美国乳腺癌分期系统的比较。
J Natl Cancer Inst. 1966 Jan;36(1):53-62.
6
American Joint Committee on Cancer Staging and end results reporting. Objectives and progress.美国癌症联合委员会分期及最终结果报告。目标与进展。
Cancer. 1965 Dec;18(12):1637-40. doi: 10.1002/1097-0142(196512)18:12<1637::aid-cncr2820181218>3.0.co;2-c.
7
The prognostic significance of palpable lymph nodes in cancer of the breast.乳腺癌中可触及淋巴结的预后意义。
Cancer. 1969 Feb;23(2):243-50. doi: 10.1002/1097-0142(196902)23:2<243::aid-cncr2820230201>3.0.co;2-9.
8
TNM clinical stage classification of breast cancer.乳腺癌的TNM临床分期分类
Int J Cancer. 1969 Nov 15;4(6):837-44. doi: 10.1002/ijc.2910040612.
9
Clinical staging of cancer and end result reporting.癌症的临床分期与最终结果报告。
CA Cancer J Clin. 1969 May-Jun;19(3):158-67. doi: 10.3322/canjclin.19.3.158.
Zotero 插件